A Pharmaceutical Executive on Trump’s Tariff Strategy
The Journal.
00:00
Navigating Pharma: Brands vs. Generics
This chapter examines the stark contrasts between brand-name and generic pharmaceutical companies, using Prozac's transition to fluoxetine as a focal point. It highlights the financial strains from tariffs on generics and the ethical dilemmas of maintaining patient access amidst rising costs.
Transcript
Play full episode
